Well Differentiated Liposarcoma clinical trials

Explore recruiting well differentiated liposarcoma clinical trials.

Recruiting well differentiated liposarcoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Well Differentiated Liposarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients

Italy, Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Well Differentiated Liposarcoma trials by city

Well Differentiated Liposarcoma clinical trials

Recruiting well differentiated liposarcoma studies right now

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

Also recruiting in Europe

Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients

Well Differentiated Liposarcoma trials by city

Other conditions